Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence. Masimo ( (MASI) ) has provided an update.
Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence. Masimo ( (MASI) ) has shared an update.
Masimo also reaffirmed the 2025 financial guidance it last stated on November 4, including Non-GAAP Revenue of $1,510 - $1,530 million, Non-GAAP operating profit of $412 - $424 million and Non-GAAP ...
Masimo said Tuesday it agreed to sell its Sound United consumer audio portfolio for $350 million to Samsung Electronics’ Harman International unit, freeing the company to focus on its professional ...
Medical tech company Masimo (NASDAQ:MASI) will be reporting earnings tomorrow after market close. Here’s what investors should know. Masimo beat analysts’ revenue expectations by 1.5% last quarter, ...
What Happened? Shares of medical tech company Masimo (NASDAQ:MASI) jumped 3.5% in the morning session after the company ...
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. The research service ...
Masimo’s first entry in the consumer smartwatch space, the W1, which launched last summer, boasts second-by-second readings of oxygen saturation, pulse rate, respiration rate, hydration index and more ...
Masimo CEO Joe Kiani does not believe that Apple will be able to solve its patent infringement issues with software, reports Bloomberg. In an interview with Bloomberg TV, Kiani said that a software ...
(Reuters) -Masimo said on Wednesday founder Joe Kiani has decided to step down as the medical device maker's CEO, days after shareholders voted to remove him from the company's board following a ...
Medical device maker Masimo Corp. hosted its 2025 Investor Day at its Irvine headquarters, covering financial targets through 2028.
Medical device company Masimo has accused Apple of patent infringement, filing a complaint against the company with the U.S. International Trade Commission yesterday. Bloomberg, which first spotted ...